Attitudes of Japanese Cardiologists Toward Anticoagulation for Nonvalvular Atrial Fibrillation and Reasons for Its Underuse

Abstract

In Japan warfarin is not used extensively for treatment of NVAF patients having risk factors and the reasons for not using antithrombotic therapy seemed inappropriate in most of patients.